GO:0005488 | binding | 38.67% (58/150) | 1.25 | 0.0 | 0.0 |
GO:0005515 | protein binding | 15.33% (23/150) | 2.07 | 0.0 | 1e-06 |
GO:0003676 | nucleic acid binding | 14.67% (22/150) | 1.92 | 0.0 | 1e-05 |
GO:0003674 | molecular_function | 49.33% (74/150) | 0.68 | 2e-06 | 0.000167 |
GO:1901363 | heterocyclic compound binding | 22.67% (34/150) | 1.15 | 6e-06 | 0.000335 |
GO:0097159 | organic cyclic compound binding | 22.67% (34/150) | 1.15 | 6e-06 | 0.000335 |
GO:0016570 | histone modification | 2.67% (4/150) | 4.95 | 6e-06 | 0.000416 |
GO:0016569 | covalent chromatin modification | 2.67% (4/150) | 4.95 | 6e-06 | 0.000416 |
GO:0006913 | nucleocytoplasmic transport | 2.0% (3/150) | 5.67 | 1.6e-05 | 0.000688 |
GO:0051169 | nuclear transport | 2.0% (3/150) | 5.67 | 1.6e-05 | 0.000688 |
GO:0043170 | macromolecule metabolic process | 16.0% (24/150) | 1.36 | 1.8e-05 | 0.000711 |
GO:0036211 | protein modification process | 7.33% (11/150) | 2.23 | 2.4e-05 | 0.000748 |
GO:0006464 | cellular protein modification process | 7.33% (11/150) | 2.23 | 2.4e-05 | 0.000748 |
GO:0065007 | biological regulation | 10.0% (15/150) | 1.82 | 2.2e-05 | 0.000804 |
GO:0051641 | cellular localization | 4.67% (7/150) | 2.91 | 3.9e-05 | 0.00113 |
GO:0043412 | macromolecule modification | 7.33% (11/150) | 2.07 | 6.5e-05 | 0.001772 |
GO:0010468 | regulation of gene expression | 7.33% (11/150) | 1.92 | 0.000166 | 0.002208 |
GO:0044237 | cellular metabolic process | 16.67% (25/150) | 1.13 | 0.000163 | 0.00224 |
GO:0009987 | cellular process | 24.67% (37/150) | 0.87 | 0.000161 | 0.002273 |
GO:0050794 | regulation of cellular process | 8.67% (13/150) | 1.73 | 0.000157 | 0.002296 |
GO:0051649 | establishment of localization in cell | 4.0% (6/150) | 2.89 | 0.000156 | 0.00236 |
GO:0050789 | regulation of biological process | 8.67% (13/150) | 1.7 | 0.000187 | 0.002414 |
GO:0031326 | regulation of cellular biosynthetic process | 7.33% (11/150) | 1.93 | 0.000155 | 0.002425 |
GO:0009889 | regulation of biosynthetic process | 7.33% (11/150) | 1.93 | 0.000155 | 0.002425 |
GO:0010556 | regulation of macromolecule biosynthetic process | 7.33% (11/150) | 1.93 | 0.000155 | 0.002425 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 7.33% (11/150) | 1.93 | 0.000155 | 0.002425 |
GO:0044260 | cellular macromolecule metabolic process | 11.33% (17/150) | 1.43 | 0.000195 | 0.002447 |
GO:0031323 | regulation of cellular metabolic process | 7.33% (11/150) | 1.86 | 0.000226 | 0.002548 |
GO:0007018 | microtubule-based movement | 2.0% (3/150) | 4.54 | 0.000245 | 0.002566 |
GO:0006928 | movement of cell or subcellular component | 2.0% (3/150) | 4.54 | 0.000245 | 0.002566 |
GO:0003777 | microtubule motor activity | 2.0% (3/150) | 4.54 | 0.000245 | 0.002566 |
GO:0006807 | nitrogen compound metabolic process | 16.0% (24/150) | 1.13 | 0.000224 | 0.00259 |
GO:0051171 | regulation of nitrogen compound metabolic process | 7.33% (11/150) | 1.87 | 0.000219 | 0.002596 |
GO:0080090 | regulation of primary metabolic process | 7.33% (11/150) | 1.87 | 0.000219 | 0.002596 |
GO:0046907 | intracellular transport | 4.0% (6/150) | 2.91 | 0.000144 | 0.002628 |
GO:1903506 | regulation of nucleic acid-templated transcription | 7.33% (11/150) | 1.94 | 0.000139 | 0.00265 |
GO:2001141 | regulation of RNA biosynthetic process | 7.33% (11/150) | 1.94 | 0.000139 | 0.00265 |
GO:0051252 | regulation of RNA metabolic process | 7.33% (11/150) | 1.94 | 0.000139 | 0.00265 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 7.33% (11/150) | 1.94 | 0.000139 | 0.00265 |
GO:0006355 | regulation of transcription, DNA-templated | 7.33% (11/150) | 1.94 | 0.000139 | 0.00265 |
GO:0019222 | regulation of metabolic process | 7.33% (11/150) | 1.84 | 0.000267 | 0.002666 |
GO:0060255 | regulation of macromolecule metabolic process | 7.33% (11/150) | 1.84 | 0.000267 | 0.002666 |
GO:0008017 | microtubule binding | 2.0% (3/150) | 4.41 | 0.000324 | 0.003165 |
GO:0035639 | purine ribonucleoside triphosphate binding | 10.67% (16/150) | 1.41 | 0.000343 | 0.003276 |
GO:0018205 | peptidyl-lysine modification | 2.0% (3/150) | 4.82 | 0.000127 | 0.003283 |
GO:0006325 | chromatin organization | 2.67% (4/150) | 3.89 | 0.000137 | 0.003334 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 6.67% (10/150) | 1.9 | 0.000361 | 0.003371 |
GO:0032555 | purine ribonucleotide binding | 10.67% (16/150) | 1.38 | 0.000416 | 0.003805 |
GO:0005524 | ATP binding | 9.33% (14/150) | 1.49 | 0.000463 | 0.003986 |
GO:0019538 | protein metabolic process | 9.33% (14/150) | 1.5 | 0.000452 | 0.004052 |
GO:0017076 | purine nucleotide binding | 10.67% (16/150) | 1.37 | 0.000462 | 0.004055 |
GO:0032553 | ribonucleotide binding | 10.67% (16/150) | 1.34 | 0.000578 | 0.004791 |
GO:0032559 | adenyl ribonucleotide binding | 9.33% (14/150) | 1.46 | 0.00057 | 0.004816 |
GO:0030554 | adenyl nucleotide binding | 9.33% (14/150) | 1.46 | 0.000597 | 0.004854 |
GO:0044267 | cellular protein metabolic process | 7.33% (11/150) | 1.66 | 0.000746 | 0.005955 |
GO:0097367 | carbohydrate derivative binding | 10.67% (16/150) | 1.3 | 0.000808 | 0.006116 |
GO:0003774 | motor activity | 2.0% (3/150) | 3.99 | 0.000798 | 0.006145 |
GO:0007017 | microtubule-based process | 2.0% (3/150) | 3.99 | 0.000798 | 0.006145 |
GO:0015631 | tubulin binding | 2.0% (3/150) | 3.75 | 0.001345 | 0.007382 |
GO:0007088 | regulation of mitotic nuclear division | 1.33% (2/150) | 5.09 | 0.001342 | 0.007459 |
GO:0005643 | nuclear pore | 1.33% (2/150) | 5.09 | 0.001342 | 0.007459 |
GO:0007346 | regulation of mitotic cell cycle | 1.33% (2/150) | 5.09 | 0.001342 | 0.007459 |
GO:0010965 | regulation of mitotic sister chromatid separation | 1.33% (2/150) | 5.09 | 0.001342 | 0.007459 |
GO:0030163 | protein catabolic process | 1.33% (2/150) | 5.09 | 0.001342 | 0.007459 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 1.33% (2/150) | 5.09 | 0.001342 | 0.007459 |
GO:0010498 | proteasomal protein catabolic process | 1.33% (2/150) | 5.09 | 0.001342 | 0.007459 |
GO:0033047 | regulation of mitotic sister chromatid segregation | 1.33% (2/150) | 5.09 | 0.001342 | 0.007459 |
GO:0033045 | regulation of sister chromatid segregation | 1.33% (2/150) | 5.09 | 0.001342 | 0.007459 |
GO:0051783 | regulation of nuclear division | 1.33% (2/150) | 5.09 | 0.001342 | 0.007459 |
GO:0043087 | regulation of GTPase activity | 1.33% (2/150) | 5.09 | 0.001342 | 0.007459 |
GO:0051983 | regulation of chromosome segregation | 1.33% (2/150) | 5.09 | 0.001342 | 0.007459 |
GO:0010564 | regulation of cell cycle process | 1.33% (2/150) | 5.09 | 0.001342 | 0.007459 |
GO:1901987 | regulation of cell cycle phase transition | 1.33% (2/150) | 5.09 | 0.001342 | 0.007459 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 1.33% (2/150) | 5.09 | 0.001342 | 0.007459 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 1.33% (2/150) | 5.09 | 0.001342 | 0.007459 |
GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 1.33% (2/150) | 5.09 | 0.001342 | 0.007459 |
GO:1905818 | regulation of chromosome separation | 1.33% (2/150) | 5.09 | 0.001342 | 0.007459 |
GO:0008144 | drug binding | 9.33% (14/150) | 1.32 | 0.001512 | 0.008192 |
GO:1901265 | nucleoside phosphate binding | 12.0% (18/150) | 1.12 | 0.001589 | 0.008406 |
GO:0000166 | nucleotide binding | 12.0% (18/150) | 1.12 | 0.001589 | 0.008406 |
GO:1901565 | organonitrogen compound catabolic process | 2.0% (3/150) | 3.82 | 0.001143 | 0.008502 |
GO:0140096 | catalytic activity, acting on a protein | 7.33% (11/150) | 1.52 | 0.001627 | 0.008503 |
GO:0018193 | peptidyl-amino acid modification | 2.0% (3/150) | 3.6 | 0.001815 | 0.009374 |
GO:0016779 | nucleotidyltransferase activity | 2.67% (4/150) | 3.05 | 0.001327 | 0.009549 |
GO:0004518 | nuclease activity | 2.67% (4/150) | 3.05 | 0.001327 | 0.009549 |
GO:0016573 | histone acetylation | 1.33% (2/150) | 4.82 | 0.001998 | 0.009745 |
GO:0033044 | regulation of chromosome organization | 1.33% (2/150) | 4.82 | 0.001998 | 0.009745 |
GO:0018393 | internal peptidyl-lysine acetylation | 1.33% (2/150) | 4.82 | 0.001998 | 0.009745 |
GO:0018394 | peptidyl-lysine acetylation | 1.33% (2/150) | 4.82 | 0.001998 | 0.009745 |
GO:0006475 | internal protein amino acid acetylation | 1.33% (2/150) | 4.82 | 0.001998 | 0.009745 |
GO:1901564 | organonitrogen compound metabolic process | 10.67% (16/150) | 1.17 | 0.002048 | 0.009881 |
GO:0006473 | protein acetylation | 1.33% (2/150) | 4.6 | 0.002775 | 0.012692 |
GO:0000398 | mRNA splicing, via spliceosome | 1.33% (2/150) | 4.6 | 0.002775 | 0.012692 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1.33% (2/150) | 4.6 | 0.002775 | 0.012692 |
GO:0000375 | RNA splicing, via transesterification reactions | 1.33% (2/150) | 4.6 | 0.002775 | 0.012692 |
GO:0043543 | protein acylation | 1.33% (2/150) | 4.6 | 0.002775 | 0.012692 |
GO:0036094 | small molecule binding | 12.0% (18/150) | 1.03 | 0.003154 | 0.014276 |
GO:0008150 | biological_process | 32.67% (49/150) | 0.52 | 0.003388 | 0.015175 |
GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.33% (2/150) | 4.41 | 0.003672 | 0.016283 |
GO:0004672 | protein kinase activity | 4.0% (6/150) | 2.01 | 0.003854 | 0.01692 |
GO:0032991 | protein-containing complex | 6.0% (9/150) | 1.54 | 0.004001 | 0.017389 |
GO:0008092 | cytoskeletal protein binding | 2.0% (3/150) | 3.04 | 0.00563 | 0.02423 |
GO:0043168 | anion binding | 11.33% (17/150) | 0.97 | 0.005922 | 0.025242 |
GO:0016070 | RNA metabolic process | 6.0% (9/150) | 1.44 | 0.006121 | 0.025836 |
GO:0003723 | RNA binding | 3.33% (5/150) | 2.1 | 0.006208 | 0.025956 |
GO:0044238 | primary metabolic process | 16.0% (24/150) | 0.77 | 0.006484 | 0.026854 |
GO:0008104 | protein localization | 2.67% (4/150) | 2.41 | 0.00676 | 0.027228 |
GO:0033036 | macromolecule localization | 2.67% (4/150) | 2.41 | 0.00676 | 0.027228 |
GO:0016740 | transferase activity | 8.67% (13/150) | 1.13 | 0.006699 | 0.027486 |
GO:0051336 | regulation of hydrolase activity | 1.33% (2/150) | 3.95 | 0.007048 | 0.028128 |
GO:0090304 | nucleic acid metabolic process | 6.67% (10/150) | 1.3 | 0.007606 | 0.030083 |
GO:0016973 | poly(A)+ mRNA export from nucleus | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:2000816 | negative regulation of mitotic sister chromatid separation | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:1905819 | negative regulation of chromosome separation | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0004813 | alanine-tRNA ligase activity | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0030623 | U5 snRNA binding | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0006419 | alanyl-tRNA aminoacylation | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0072523 | purine-containing compound catabolic process | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0017070 | U6 snRNA binding | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0009261 | ribonucleotide catabolic process | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0009214 | cyclic nucleotide catabolic process | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0006198 | cAMP catabolic process | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0017069 | snRNA binding | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0006195 | purine nucleotide catabolic process | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0009154 | purine ribonucleotide catabolic process | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:1901988 | negative regulation of cell cycle phase transition | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0006515 | protein quality control for misfolded or incompletely synthesized proteins | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:1901991 | negative regulation of mitotic cell cycle phase transition | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0045930 | negative regulation of mitotic cell cycle | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0045839 | negative regulation of mitotic nuclear division | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0033048 | negative regulation of mitotic sister chromatid segregation | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0033046 | negative regulation of sister chromatid segregation | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0017108 | 5'-flap endonuclease activity | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0033557 | Slx1-Slx4 complex | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0048256 | flap endonuclease activity | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0031577 | spindle checkpoint | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0010948 | negative regulation of cell cycle process | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0004520 | endodeoxyribonuclease activity | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0051784 | negative regulation of nuclear division | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0071174 | mitotic spindle checkpoint | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0031144 | proteasome localization | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0071173 | spindle assembly checkpoint | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0007094 | mitotic spindle assembly checkpoint | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0007093 | mitotic cell cycle checkpoint | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0071630 | nuclear protein quality control by the ubiquitin-proteasome system | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0051985 | negative regulation of chromosome segregation | 0.67% (1/150) | 6.41 | 0.01176 | 0.031673 |
GO:0006468 | protein phosphorylation | 3.33% (5/150) | 1.87 | 0.011888 | 0.031822 |
GO:0071704 | organic substance metabolic process | 16.67% (25/150) | 0.72 | 0.008172 | 0.032031 |
GO:0033043 | regulation of organelle organization | 1.33% (2/150) | 3.82 | 0.008393 | 0.032605 |
GO:0140110 | transcription regulator activity | 4.67% (7/150) | 1.5 | 0.012354 | 0.032869 |
GO:0071705 | nitrogen compound transport | 2.67% (4/150) | 2.3 | 0.008794 | 0.033863 |
GO:0006139 | nucleobase-containing compound metabolic process | 7.33% (11/150) | 1.19 | 0.008933 | 0.0341 |
GO:0008380 | RNA splicing | 1.33% (2/150) | 3.71 | 0.009843 | 0.03631 |
GO:0051128 | regulation of cellular component organization | 1.33% (2/150) | 3.71 | 0.009843 | 0.03631 |
GO:0070646 | protein modification by small protein removal | 1.33% (2/150) | 3.71 | 0.009843 | 0.03631 |
GO:0016579 | protein deubiquitination | 1.33% (2/150) | 3.71 | 0.009843 | 0.03631 |
GO:0071702 | organic substance transport | 2.67% (4/150) | 2.24 | 0.010186 | 0.037264 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4.0% (6/150) | 1.7 | 0.010585 | 0.038405 |
GO:0016310 | phosphorylation | 3.33% (5/150) | 1.8 | 0.014534 | 0.038436 |
GO:0070647 | protein modification by small protein conjugation or removal | 1.33% (2/150) | 3.41 | 0.014798 | 0.038899 |
GO:0043167 | ion binding | 16.0% (24/150) | 0.67 | 0.01514 | 0.039562 |
GO:0016301 | kinase activity | 4.0% (6/150) | 1.68 | 0.01122 | 0.040375 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3.33% (5/150) | 1.89 | 0.011482 | 0.040648 |
GO:0051726 | regulation of cell cycle | 1.33% (2/150) | 3.6 | 0.011395 | 0.040671 |
GO:0046483 | heterocycle metabolic process | 7.33% (11/150) | 1.07 | 0.016469 | 0.042781 |
GO:0006725 | cellular aromatic compound metabolic process | 7.33% (11/150) | 1.06 | 0.017222 | 0.044472 |
GO:0003677 | DNA binding | 4.67% (7/150) | 1.39 | 0.0178 | 0.045698 |
GO:0034613 | cellular protein localization | 1.33% (2/150) | 3.24 | 0.01858 | 0.045824 |
GO:0070727 | cellular macromolecule localization | 1.33% (2/150) | 3.24 | 0.01858 | 0.045824 |
GO:0019783 | ubiquitin-like protein-specific protease activity | 1.33% (2/150) | 3.24 | 0.01858 | 0.045824 |
GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity | 1.33% (2/150) | 3.24 | 0.01858 | 0.045824 |
GO:0101005 | ubiquitinyl hydrolase activity | 1.33% (2/150) | 3.24 | 0.01858 | 0.045824 |
GO:0050790 | regulation of catalytic activity | 1.33% (2/150) | 3.24 | 0.01858 | 0.045824 |
GO:0065009 | regulation of molecular function | 1.33% (2/150) | 3.24 | 0.01858 | 0.045824 |